Clinical AI Inventory: How Health Systems Track AI Tools

A clinical AI inventory is the record a health system uses to know which AI tools are in use, requested, piloted, retired, or under review. Without that inventory, AI governance becomes reactive. Leaders may know about a large vendor deployment but miss a departmental model, an ambient documentation pilot, a reporting assistant, or a locally configured decision-support rule that behaves like an AI tool in practice.

The inventory is not paperwork for its own sake. It is the control surface for Clinical AI Governance Framework, Monitoring Clinical AI After Deployment, and How Hospitals Evaluate Clinical AI Vendors. If the organization cannot list the tool, it cannot reliably assign ownership, review privacy risk, monitor performance, retrain users, or decide when a vendor update needs re-review.

What Belongs in a Clinical AI Inventory

The inventory should include any AI-enabled or algorithmic system that affects clinical care, clinical workflow, patient-facing communication, documentation, quality review, or operational decisions near patient care. That includes regulated device software, predictive decision support, ambient documentation, imaging AI, triage tools, vendor platforms, internally built models, rules tuned with machine learning, and generative AI workflows approved for clinical use.

It should also include tools that are still in intake or pilot. Waiting until broad deployment hides risk during the period when workflow assumptions, data handling, and ownership are usually least stable.

Core Fields to Track

A useful inventory record should answer practical questions quickly. At minimum, track:

• tool name, vendor or internal owner, and version
• clinical owner, technical owner, and operational owner
• intended use, intended users, and patient population
• workflow location, output type, and expected user action
• data inputs, PHI exposure, retention, and third-party handling
• regulatory status when relevant
• validation evidence, local acceptance testing, and known limits
• risk tier, monitoring metrics, and review cadence
• training requirements, escalation rules, and pause criteria
• model, prompt, threshold, and workflow change history

Those fields should be kept current enough to support decisions, not just complete enough to pass an intake form once.

Inventory Should Distinguish Risk

Not every AI tool needs the same review depth. A patient-safety diagnostic tool, a radiology triage system, a clinical documentation assistant, and an administrative summarization tool have different risk profiles. The inventory should make those differences visible through risk tiering.

NIST's AI Risk Management Framework is useful here because it separates governance from individual system risk work. At the inventory level, the organization governs. At the tool level, it maps context, measures risk and performance, and manages the tool over time.

Use Source Attributes as a Practical Model

ONC's HTI-1 decision support intervention materials give health systems a practical vocabulary for AI transparency. Source attributes such as intended use, intended users, intended patient population, output type, known limitations, development details, performance, validation, and risk management are exactly the kinds of fields that belong in a clinical AI inventory.

Even when a tool is not directly governed by certified health IT requirements, the same information helps clinicians and governance teams understand what the tool is supposed to do and where it should not be applied.

Inventory Must Include Change Control

An AI inventory that does not track change is incomplete. Vendor model updates, prompt changes, threshold shifts, user-interface changes, new data feeds, and expanded use cases can alter how a tool behaves. The record should show what changed, who reviewed it, whether validation was repeated, whether training changed, and whether monitoring metrics were adjusted.

This matters for regulated device software, but it also matters for non-device AI used in sensitive workflows. Many implementation failures happen because a tool remains listed as approved while the practical behavior of the tool has changed.

Inventory Ownership

The inventory should not belong only to IT. Clinical leadership, informatics, privacy, security, compliance, quality, patient safety, procurement, and the service line using the tool all need a role. CHAI governance playbooks and Joint Commission responsible-use framing both point toward cross-functional governance because AI risk is not only technical.

A workable model is to make one governance group accountable for the inventory, while each tool record has named clinical, technical, and operational owners. That avoids a central registry with no local accountability.

How the Inventory Supports Decisions

A maintained inventory helps answer practical questions:

• Which tools touch PHI outside the primary clinical environment?
• Which tools are regulated device software or may need regulatory review?
• Which tools have not had local acceptance testing?
• Which tools depend on a vendor update cycle?
• Which tools need user retraining after workflow or model changes?
• Which tools lack monitoring metrics or pause criteria?
• Which tools overlap and may create duplicate or conflicting outputs?

Those are not abstract governance questions. They determine whether clinical AI can scale without losing control.

Related Clinical AI Topics

• AI Inventory and Release Governance
• AI Product Release Criteria for Clinical Tools
• FDA AI Inspection Readiness for Clinical AI Software
• Clinical AI Governance Framework
• Monitoring Clinical AI After Deployment
• Privacy and HIPAA

Reviewed: August 14, 2026. Next review: November 14, 2026.